Rituximab is an injectable drug that is in a class of medications called monoclonal antibiodies. It is used in the treatment of non-Hodgkins lymphoma and also in the treatment of rheumatoid arthritis.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Slow my Devic's progress | 14 |
|
3 | ||||
| Other | 1 | 0 |
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Other
|
3 | 43% |
|
|
Course of treatment ended
|
3 | 43% |
|
|
Doctor's advice
|
2 | 29% |
|
|
Expense
|
1 | 14% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 22, 2009.